5E). Similar

to the observed effect on IFN-β, poly(I:C) induced higher expression of other genes sensitive for TRIF-dependent regulation (IFN-α1, IFN-α2 and CCL5) when the cells received LPS pre-treatment whereas we did not consistently observe a similar effect on CXCL10 expression. Overall, our results indicated the downregulation of MyD88-dependent TLR signals in response to LPS pre-treatment of developing MoDCs. The TRIF-dependent TLR pathways, on the other hand, might remain functional following a persistent LPS stimulation. We compared gene expression of chemokine molecules in MoDCs cultured with or without LPS for 2 days and observed a significant increase in the expression of CCL5, CCL18, CCL19, CCL23, CCL24, CCL26, CXCL1, www.selleckchem.com/products/dabrafenib-gsk2118436.html CXCL2 and CXCL5, in the presence Torin 1 chemical structure of LPS that suggests an increased ability of the LPS-treated MoDCs to attract both resting and activated T cells, as well as granulocytes (Fig. 6A). In addition to such possible contribution to the cellular influx associated with tissue inflammation, LPS-treated MoDCs might

increase their motility by cleaving extracellular matrix constituents as suggested by the elevated MMP7, MMP9 and MMP12 mRNA levels in these cells. In order to understand whether MoDCs that received activation signals at early stages of their development could obtain migratory potential towards lymphoid tissues, and contribute to naïve T-cell activation, we studied their chemokine receptor pattern during the first day of culture in the presence of a wide range of activation stimuli. As MoDCs responded readily with a strong cytokine production when receiving activation Carbohydrate signals (day 1) and became later functionally exhausted and incapable to respond to further stimulation (day 2), an early chemokine receptor modulation might be

prerequisite for the migration of functional, not-exhausted MoDCs to lymphoid tissues. We studied CCR5 and CCR7 expression on MoDCs that received activation signals during the first day of their culture and compared these cells with MoDCs that received the same activation signals at a more differentiated stage, at day 5 of the culture. Interestingly, CCR5, a chemokine receptor that primes migration to inflamed peripheral tissues, was not downregulated and CCR7 was not induced when MoDCs received activation signals early in their development. On the contrary, MoDCs that developed for 5 days without activation downregulated CCR5 in response to LPS, HKSA, zymosan or CD40L and several of the tested activation signals induced the expression of CCR7 on these cells (Fig. 6B).